IMAXIMAX CORP

NYSE imax.com


$ 17.14 $ -0.31 (-1.78 %)    

Friday, 26-Apr-2024 15:59:57 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 17.15
$ 17.39
$ 0.00 x 0
$ 0.00 x 0
$ 16.91 - $ 17.51
$ 13.20 - $ 21.82
1,724,835
na
915.91M
$ 0.83
$ 35.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 10-25-2023 09-30-2023 10-Q
4 07-26-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 10-31-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-27-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 03-04-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 07-28-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-30-2019 06-30-2019 10-Q
21 04-26-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 10-25-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 05-01-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-26-2017 06-30-2017 10-Q
29 04-20-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 10-20-2016 09-30-2016 10-Q
32 07-20-2016 06-30-2016 10-Q
33 04-21-2016 03-31-2016 10-Q
34 02-24-2016 12-31-2015 10-K
35 10-28-2015 09-30-2015 10-Q
36 07-23-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-19-2015 12-31-2014 10-K
39 10-23-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benchmark-reiterates-buy-on-imax-maintains-22-price-target

Benchmark analyst Mike Hickey reiterates Imax (NYSE:IMAX) with a Buy and maintains $22 price target.

 wedbush-reiterates-outperform-on-imax-maintains-22-price-target

Wedbush analyst Alicia Reese reiterates Imax (NYSE:IMAX) with a Outperform and maintains $22 price target.

 barrington-research-maintains-outperform-on-imax-maintains-24-price-target

Barrington Research analyst James Goss maintains Imax (NYSE:IMAX) with a Outperform and maintains $24 price target.

 imax-reports-better-than-expected-q1-results

Imax reported quarterly earnings of 15 cents per share which beat the analyst consensus estimate of 10 cents by 50%. Quarterly ...

 imax-q1-adj-eps-015-beats-010-estimate-sales-7912m-beat-7818m-estimate

Imax (NYSE:IMAX) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.10 by 50 percen...

 imax-and-cinenova-launch-partnership-with-four-new-imax-with-laser-systems-across-turkey

New Collaboration Brings State-of-the Art IMAX with Laser to Thriving Turkish Cinema Market for First TimeNEW YORK and ISTANBUL...

 barrington-research-maintains-outperform-on-imax-maintains-24-price-target

Barrington Research analyst James Goss maintains Imax (NYSE:IMAX) with a Outperform and maintains $24 price target.

 imax-gaining-on-all-grounds---analyst-highlights-streamsmart-technology-and-global-expansion-as-catalysts

Wedbush analyst Alicia Reese reaffirms Outperform rating on IMAX ahead of Q1 FY24 earnings. Expectations soar with projected r...

 wedbush-reiterates-outperform-on-imax-maintains-22-price-target

Wedbush analyst Alicia Reese reiterates Imax (NYSE:IMAX) with a Outperform and maintains $22 price target.

 benchmark-reiterates-buy-on-imax-maintains-22-price-target

Benchmark analyst Mike Hickey reiterates Imax (NYSE:IMAX) with a Buy and maintains $22 price target.

 imax-and-miraj-cinemas-enter-partnership-with-three-new-imax-with-laser-locations-across-india

New Collaboration Marks IMAX's Largest Agreement for New Locations in India in Five YearsLAS VEGAS, April 10, 2024 /PRNewsw...

 wedbush-reiterates-outperform-on-imax-maintains-22-price-target

Wedbush analyst Alicia Reese reiterates Imax (NYSE:IMAX) with a Outperform and maintains $22 price target.

 benchmark-reiterates-buy-on-imax-maintains-22-price-target

Benchmark analyst Mike Hickey reiterates Imax (NYSE:IMAX) with a Buy and maintains $22 price target.

 imax-and-major-cineplex-expand-partnership-with-three-new-imax-with-laser-locations-across-thailand

New Agreement Furthers Rapid Expansion of IMAX across Southeast Asia

 imax-and-bona-film-group-expand-partnership-with-three-new-imax-locations-in-china

Longstanding Partners Strike First Post-COVID Agreement as Chinese Moviegoing Continues to Surge

 imax-to-unveil-new-live-streaming-optimization-tool--streamsmart-on-air--at-nab-2024

IMAX Corporation NYSE: IMAX) will debut a new version of its StreamSmart™ enterprise software for live and linear workflows at ...

 imax-ceo-richard-gelfond-praised-by-oppenheimer-co-producer-emma-thomas-during-oscar-acceptance-speech

The Oscar-winning producer of "Oppenheimer," Emma Thomas, expressed her gratitude to IMAX CEO Richard Gelfond during he...

 box-office-smash-dune-2-drew-millions-to-movie-theaters-one-dying-man-got-to-see-the-movie-early-the-heartwarming-story-of-fandom

The highly anticipated sequel "Dune Part Two" had a huge opening weekend box office. The story of one man who got to se...

 imax-secures-box-office-win-with-dune-part-2-analyst-predicts-more-high-profile-projects-and-global-expansion

IMAX garners renewed enthusiasm as Wedbush analyst Alicia Reese maintains an Outperform rating. IMAX will have Dune Part 2 on i...

 barrington-research-reiterates-outperform-on-imax-maintains-24-price-target

Barrington Research analyst James Goss reiterates Imax (NYSE:IMAX) with a Outperform and maintains $24 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION